Gilead Sciences Inc to ramp up production of experimental COVID-19 treatment with international partners

In a statement Gilead Sciences Inc, the maker of the closely-watched experimental coronavirus drug remdesivir stated, it will continue to work with international partners to expand the production of its potential COVID-19 treatment. Gilead said, it expects to have more than one million remdesivir treatment courses manufactured by December, “with plans to be able to…

Virus outbreak at Taiwan Semiconductor Manufacturing Company set to impact its Q3 results

Despite the outbreak, which has caused shipment delays, TSMC has maintained its single digit growth forecast. Taiwan Semiconductor Manufacturing Company Ltd, the world’s largest contract chipmaker stated as a result of computer virus outbreak in its systems, its third-quarter results have been affected. TSMC, a major supplier for Apple Inc, stated the virus infected a…